本文關(guān)鍵詞： 胸腔 導(dǎo)管留置 地塞米松 異煙肼 結(jié)核性胸膜炎　出處：《中外醫(yī)療》2016年34期 　論文類型：期刊論文

【摘要】：目的研究胸腔導(dǎo)管留置聯(lián)合注射地塞米松、異煙肼治療結(jié)核性胸膜炎的應(yīng)用價(jià)值。方法選擇2014年1月—2015年12月河北省廊坊市人民醫(yī)院收治的120例結(jié)核性胸膜炎患者,按照隨機(jī)數(shù)字表法將其分成研究組與對照組,每組60例,研究組實(shí)施胸腔導(dǎo)管留置聯(lián)合注射地塞米松、異煙肼治療;對照組經(jīng)B超定位胸腔穿刺抽液治療,比較分析兩組臨床療效及不良反應(yīng)。結(jié)果研究組治療總有效率為95.0%,對照組的治療總有效率為80.0%,兩組治療總有效率比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)。研究組患者胸腔積液引流量為(1 103.8±276.6)m L,低于對照組胸腔積液引流量(1 763.2±234.5)ml(P0.05);研究組胸水消失時(shí)間為(7.3±2.6)d,短于對照組胸水消失時(shí)間(12.4±3.2)d(P0.01);研究組胸膜肥厚粘連發(fā)生率為5.0%,低于對照組胸膜肥厚粘連發(fā)生率16.7%(P0.05);研究組氣胸等不良反應(yīng)發(fā)生率為1.7%,低于對照組氣胸等不良反應(yīng)發(fā)生率10.0%(P0.05)。結(jié)論胸腔導(dǎo)管留置聯(lián)合注射地塞米松、異煙肼治療結(jié)核性胸膜炎效果顯著,引流胸液量大,胸腔穿刺數(shù)較少,胸水消退時(shí)間短、不良反應(yīng)少,值得應(yīng)用及推廣。
[Abstract]:Objective to study the value of thoracic catheter indwelling combined with dexamethasone injection and isoniazid in the treatment of tuberculous pleurisy. Methods 120 cases of tuberculous pleurisy treated in Langfang people's Hospital of Hebei Province from January 2014 to December 2015 were selected. According to the method of random digital table, it was divided into study group and control group with 60 cases in each group. The study group was treated with thoracic catheter indwelling combined with dexamethasone and isoniazid injection. Results the total effective rate of the study group was 95.0, the total effective rate of the control group was 80.00.There was significant difference in the total effective rate between the two groups. The volume of pleural effusion in the study group was 1.103.8 鹵276.6mL, which was lower than that in the control group (1763.2 鹵234.5ml / ml), the time of pleural effusion disappearance in the study group was 7.3 鹵2.6d, which was shorter than that in the control group (12.4 鹵3.2dg / ml), and the incidence of pleural hypertrophy in the study group was 5.0, which was lower than that in the control group. The incidence of adverse reactions such as pneumothorax in the study group was 1.7, which was lower than that in the control group (10.0 and P 0.05). Conclusion the incidence of thoracic catheter indwelling combined with dexamethasone injection is lower than that of the control group. Isoniazid is effective in treating tuberculous pleurisy with large amount of draining pleural effusion, less number of pleural puncture, short time of pleural effusion regression and less adverse reactions. It is worth applying and popularizing.
【作者單位】： 河北省廊坊市人民醫(yī)院胸外科;河北省廊坊市疾病預(yù)防控制中心結(jié)防科;
【分類號(hào)】：R521.7
，

本文編號(hào)：1545243